Clinical outcomes of multidimensional association of type 2 diabetes mellitus, COVID-19 and sarcopenia: an algorithm and scoping systematic evaluation

References

• Abbatecola, A.M., et al., 2011. Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction. The journal of nutrition, health & aging, 15 (10), 890–895.
   PubMed Web of Science ®Google Scholar
• Aguila, E.J.T., Lontok, M.A.D., and Francisco, C.P.D., 2020. Follow your gut: challenges in nutritional therapy during the COVID-19 pandemic. Clinical gastroenterology and hepatology, 18 (11), 2638–2639.
   PubMed Web of Science ®Google Scholar
• Al-Taie, A., and Koseoğlu, A., 2021. Dual impact from coincide potential complications of cancer therapy and sarcopenia: a narrative review. OCP, 17 (2), 1–24.
   Google Scholar
• Al-Taie, A., and Victoria, A.O., 2020. Supplementary medicines and antioxidants in viral infections: a review of proposed effects for COVID-19. BBRJ, 4 (5), 19.
   Google Scholar
• Bakilan, F., et al., 2021. The effect of covid-19 pandemic on sarcopenia, quality of life and pain: a one-year follow-up st udy. Turkish journal of geriatrics, 24 (3), 330–341.
   Google Scholar
• Barazzoni, R., et al., 2020. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clinical nutrition, 39 (6), 1631–1638.
   PubMed Web of Science ®Google Scholar
• Bellelli, G., et al., 2020. Frailty index predicts poor outcome in COVID-19 patients. Intensive care medicine, 46 (8), 1634–1636.,.
   PubMed Web of Science ®Google Scholar
• Bello-Chavolla, O.Y., et al., 2020. Predicting mortality due to SARS-CoV-2: a mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico. Journal of clinical endocrinology and metabolism., 105 (8), dgaa346.
   PubMed Web of Science ®Google Scholar
• Berchtold, L.A., et al., 2016. Cytokines and pancreatic β-Cell apoptosis. Advances in clinical chemistry, 75, 99–158.
   PubMed Web of Science ®Google Scholar
• Beretta, M.V., et al., 2020. Sarcopenia and Type 2 diabetes mellitus as predictors of 2-year mortality after hospital discharge in a cohort of hospitalized adults. Diabetes research and clinical practice, 159, 107969.
   PubMed Web of Science ®Google Scholar
• Bouchi, R., et al., 2017. Insulin treatment attenuates decline of muscle mass in Japanese patients with type 2 diabetes. Calcified tissue international, 101 (1), 1–8.
   PubMed Web of Science ®Google Scholar
• Bouchi, R., et al., 2017. Sarcopenia is associated with incident albuminuria in patients with type 2 diabetes: a retrospective observational study. Journal of diabetes investigation, 8 (6), 783–787.
   PubMed Web of Science ®Google Scholar
• Cariou, B., et al., 2020. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia, 63 (8), 1500–1515.
   PubMed Web of Science ®Google Scholar
• CDC COVID-19 Response Team, 2020. Preliminary estimates of the prevalence of selected underlying health conditions among patients with Coronavirus Disease 2019 – United States, February 12–March 28, 2020. Morbidity and mortality weekly report, 69 (13), 382–386.
   PubMed Web of Science ®Google Scholar
• Çeliker, M., Selçuk, M.Y., and Olt, S., 2018. Sarcopenia in diabetic nephropathy: a cross-sectional study. Romanian journal of internal medicine, 56 (2), 102–108.
   PubMedGoogle Scholar
• Chen, G., et al., 2020. Clinical and immunological features of severe and moderate Coronavirus disease 2019. The journal of clinical investigation, 130 (5), 2620–2629.
   PubMed Web of Science ®Google Scholar
• Chinese Center for Disease Control and Prevention, 2020. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chinese journal of epidemiology, 2020, 145–151.
   Google Scholar
• Cruz-Jentoft, A.J., et al., 2010. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in older people. Age and Ageing, 39 (4), 412–423.
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft, A.J., et al., 2019. Sarcopenia: revised European consensus on definition and diagnosis. Age ageing, 48 (1), 16e31.
   Web of Science ®Google Scholar
• Cui, M., et al., 2020. A cross-sectional study: associations between sarcopenia and clinical characteristics of patients with type 2 diabetes. Medicine, 99 (2), e18708.
   PubMed Web of Science ®Google Scholar
• Cummings, M.J., et al., 2020. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. The lancet, 395 (10239), 1763–1770.
   PubMed Web of Science ®Google Scholar
• D’Onofrio, N., et al., 2021. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte. Cardiovascular diabetology, 20 (1), 99.
   PubMed Web of Science ®Google Scholar
• de Freitas, M.M., et al., 2020. Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus. Experimental gerontology, 132, 110835.
   PubMed Web of Science ®Google Scholar
• de Rekeneire, N., et al., 2006. Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study. Diabetes care, 29 (8), 1902–1908.
   PubMed Web of Science ®Google Scholar
• Deshpande, A.D., Harris-Hayes, M., and Schootman, M., 2008. Epidemiology of diabetes and diabetes-related complications. Physical therapy, 88 (11), 1254–1264.
   PubMed Web of Science ®Google Scholar
• Docherty, A.B., et al., 2020. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ, 369, m1985.
   PubMed Web of Science ®Google Scholar
• Drucker, D.J., 2020. Coronavirus infections and Type 2 diabetes-shared pathways with therapeutic implications. Endocrine reviews, 41 (3), bnaa011.
   PubMed Web of Science ®Google Scholar
• Evans, W.J., and Lexell, J., 1995. Human aging, muscle mass, and fiber type composition. The Journals of gerontology series A, 50A (Special), 11–16.
   Google Scholar
• Fernandez, C., et al., 2018. Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality. Journal of internal medicine, 284 (4), 377–387.
   PubMed Web of Science ®Google Scholar
• Fukuoka, Y., et al., 2019. Importance of physical evaluation using skeletal muscle mass index and body fat percentage to prevent sarcopenia in elderly Japanese diabetes patients. Journal of diabetes investigation, 10 (2), 322–330.
   PubMed Web of Science ®Google Scholar
• Fung, F.Y., et al., 2019. Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting. BMC geriatrics, 19 (1), 122.
   PubMedGoogle Scholar
• Garbati, M.A., et al., 2016. A comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes. PLoS one, 11 (11), e0165978.
   PubMed Web of Science ®Google Scholar
• Gfp, A., et al., 2020. Myosteatosis and prognosis in cancer: systematic review and meta-analysis. Critical reviews in oncology/hematology, 145, 102839.
   PubMed Web of Science ®Google Scholar
• Ghosh, A., et al., 2021. Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study. Diabetes & metabolic syndrome , 15 (1), 215–215220.
   PubMed Web of Science ®Google Scholar
• Giraudo, C., et al., 2021. Reduced muscle mass as predictor of intensive care unit hospitalization in COVID-19 patients. PLoS one, 16 (6), e0253433.
   PubMed Web of Science ®Google Scholar
• Gomes, M.J., et al., 2017. Skeletal muscle aging: influence of oxidative stress and physical exercise. Oncotarget, 8 (12), 20428–20440.
   PubMedGoogle Scholar
• Goyal, R., et al., 2012. Evaluation of TNF-α and IL-6 levels in obese and non-obese diabetics: pre- and postinsulin effects. North American journal of medical sciences, 4 (4), 180–184.
   PubMedGoogle Scholar
• Guan, W.J., et al., 2020. China medical treatment expert group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. European respiratory journal, 55 (5), 2000547.
   PubMed Web of Science ®Google Scholar
• Guerrero, N., et al., 2016. Premature loss of muscle mass and function in type 2 diabetes. Diabetes research and clinical practice, 117, 32–38.
   PubMed Web of Science ®Google Scholar
• Gupta, P., et al., 2017. Association between the severity of diabetic retinopathy and falls in an Asian population with diabetes: the Singapore Epidemiology of Eye Diseases Study. JAMA ophthalmology, 135 (12), 1410–1416.
   PubMed Web of Science ®Google Scholar
• Haddad, F., et al., 2005. IL-6-induced skeletal muscle atrophy. Journal of applied physiology, 98 (3), 911–917.
   Google Scholar
• Hamer, M., and Molloy, G. J., 2009. Association of C-reactive protein and muscle strength in the English longitudinal study of ageing. Age, 31 (3), 171–177.
   PubMedGoogle Scholar
• Han, P., et al., 2016. Incidence, risk factors, and the protective effect of high body mass index against Sarcopenia in Suburb-Dwelling elderly Chinese populations. The journal of nutrition, health and aging, 20 (10), 1056–1060.
   PubMed Web of Science ®Google Scholar
• Haraj, N.E., et al., 2021. Nutritional status assessment in patients with Covid-19 after discharge from the intensive care unit. Clinical nutrition ESPEN, 41, 423–428.
   PubMed Web of Science ®Google Scholar
• Hasegawa, Y., et al., 2021. Effect of COVID-19 pandemic on the change in skeletal muscle mass in older patients with Type 2 diabetes: a retrospective cohort study. International journal of environmental research and public health, 18 (8), 4188.
   PubMed Web of Science ®Google Scholar
• Hewitt, J., et al., 2020. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. The lancet, 5 (8), e444–e451.
   Web of Science ®Google Scholar
• Hong, K.S., et al., 2020. Clinical features and outcomes of 98 patients hospitalized with SARS-CoV-2 infection in Daegu, South Korea: a brief descriptive study. Yonsei medical journal, 61 (5), 431–437.
   PubMed Web of Science ®Google Scholar
• Hong, S., et al., 2017. Relative muscle mass and the risk of incident type 2 diabetes: a cohort study. PLoS One, 12 (11), e0188650.
   PubMed Web of Science ®Google Scholar
• Hussain, A., Bhowmik, B., and do Vale Moreira, N. C., 2020. COVID-19 and diabetes: knowledge in progress. Diabetes research and clinical practice, 162, 108142.
   PubMed Web of Science ®Google Scholar
• Ida, S., et al., 2018. Association between dynapenia and decline in higher-level functional capacity in older men with diabetes. Geriatrics & gerontology international, 18 (9), 1393–1397.
   PubMed Web of Science ®Google Scholar
• Janssen, I., Heymsfield, S. B., and Ross, R., 2002. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. Journal of the american geriatrics society, 50 (5), 889–896.
   PubMed Web of Science ®Google Scholar
• Kaji, A., et al., 2019. Sarcopenia is associated with tongue pressure in older patients with type 2 diabetes: a cross-sectional study of the KAMOGAWA-DM cohort study. Geriatrics & gerontology international, 19 (2), 153–158.
   PubMed Web of Science ®Google Scholar
• Kalyani, R.R., Corriere, M., and Ferrucci, L., 2014. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. The lancet, 2 (10), 819–829.
   Web of Science ®Google Scholar
• Kara, Ö., et al., 2021. Grip strength as a predictor of disease severity in hospitalized COVID-19 patients. Heart & lung, 50 (6), 743–747.
   PubMed Web of Science ®Google Scholar
• Khateeb, J., et al., 2019. Diabetes and Lung Disease: a neglected relationship. The review of diabetic studies, 15, 1–15.
   PubMedGoogle Scholar
• Kim, J.W., et al., 2021. Prognostic implication of baseline sarcopenia for length of Hospital Stay and survival in patients with Coronavirus Disease 2019. The journals of gerontology, 76 (8), e110–e116.
   Google Scholar
• King, D. E., et al., 2003. C-reactive protein and glycemic control in adults with diabetes. Diabetes care, 26 (5), 1535–1539.
   PubMed Web of Science ®Google Scholar
• Klein, O.L., et al., 2016. Hispanics/Latinos with type 2 diabetes have functional and symptomatic pulmonary impairment Mirroring kidney microangiopathy: findings from the Hispanic community health Study/Study of Latinos (HCHS/SOL). Diabetes care, 39 (11), 2051–2057.
   PubMed Web of Science ®Google Scholar
• Klekotka, R.B., Mizgała, E., and Król, W., 2015. The etiology of lower respiratory tract infections in people with diabetes. Pneumonologia i Alergologia Polska, 83 (5), 401–408.
   PubMedGoogle Scholar
• Kumar, A., et al., 2020. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes & metabolic syndrome , 14 (4), 535–545.
   PubMed Web of Science ®Google Scholar
• Kwan, P., 2013. Sarcopenia, a neurogenic syndrome? Journal of aging research, 2013, 791679.
   PubMedGoogle Scholar
• Landi, F., et al., 2012. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clinical nutrition, 31 (5), 652–658.
   PubMed Web of Science ®Google Scholar
• Lang, C.H., et al., 2002. TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation. American journal of physiology, 282 (2), E336–347.,
   Google Scholar
• Laviada-Molina, H. A., et al., 2020. Working hypothesis for glucose metabolism and SARS-CoV-2 replication: interplay between the hexosamine pathway and interferon RF5 triggering hyperinflammation. role of BCG Vaccine? Frontiers in endocrinology, 11, 514.
   PubMed Web of Science ®Google Scholar
• Lee, C.G., et al., 2011. Association between insulin resistance and lean mass loss and fat mass gain in older men without diabetes mellitus. Journal of the American geriatrics society, 59 (7), 1217–1224.
   PubMed Web of Science ®Google Scholar
• Levy, D., et al., 2022. Long term follow-up of sarcopenia and malnutrition after hospitalization for COVID-19 in conventional or intensive care units. Nutrients, 14 (4), 912.
   PubMed Web of Science ®Google Scholar
• Li, D., 2020. Clinical characteristics of 80 patients with COVID-19 in Zhuzhou City. Chinese prevention and control, 19 (3), 227–233.
   Google Scholar
• Liao, Y.H., et al., 2020. Novel molecular evidence related to COVID-19 in patients with Diabetes Mellitus. Journal of clinical medicine, 9 (12), 3962.
   PubMed Web of Science ®Google Scholar
• Liccini, A., and Malmstrom, T.K., 2016. Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes Mellitus. Journal of the American medical directors association, 17 (9), 846–851.
   PubMed Web of Science ®Google Scholar
• Liu, B., et al., 2020. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? Journal of autoimmunity, 111, 102452.
   PubMed Web of Science ®Google Scholar
• Liu, F., et al., 2020. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. Journal of clinical virology, 127, 104370.
   PubMed Web of Science ®Google Scholar
• Liu, Y., et al., 2019. Resistance exercise intensity is correlated with attenuation of hba1c and insulin in patients with type 2 diabetes: a systematic review and meta-analysis. International journal of environmental research and public health, 16 (1), 140.
   PubMed Web of Science ®Google Scholar
• Luo, P., et al., 2020. Tocilizumab treatment in COVID-19: a single center experience. Journal of medical virology, 92 (7), 814–818.
   PubMed Web of Science ®Google Scholar
• Ma, Y., et al., 2020. The association between frailty and severe disease among COVID-19 patients aged over 60 years in China: a prospective cohort study. BMC medicine, 18 (1), 274.
   PubMed Web of Science ®Google Scholar
• Ma, Y., et al., 2021. The role of SARC-F scale in predicting progression risk of COVID-19 in elderly patients: a prospective cohort study in Wuhan. BMC geriatr, 21 (1), 355.
   PubMed Web of Science ®Google Scholar
• Makki, K., Froguel, P., and Wolowczuk, I., 2013. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN inflammation, 2013, 139239.
   PubMedGoogle Scholar
• Manda, C.M., et al., 2020. Handgrip strength predicts new prediabetes cases among adults: a prospective cohort study. Preventive medicine reports, 17, 101056.
   PubMedGoogle Scholar
• Manrique-Espinoza, B., et al., 2017. Sarcopenia is associated with physical and mental components of health-related quality of life in older adults. Journal of the American medical directors association, 18 (7), 636.e1–e5.
   PubMed Web of Science ®Google Scholar
• Marfella, R., et al., 2022a. Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes. Nature communications, 13 (1), 2318.
   PubMed Web of Science ®Google Scholar
• Marfella, R., et al., 2020. Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients. Diabetes & metabolism, 46 (5), 403–405.
   PubMed Web of Science ®Google Scholar
• Marfella, R., et al., 2021. SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction. Critical Care, 25 (1), 217.
   PubMed Web of Science ®Google Scholar
• Marfella, R., et al., 2022b. Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study. Diabetes, obesity & metabolism, 24 (1), 160–165.
   PubMed Web of Science ®Google Scholar
• Matarese, A., et al., 2020. miR-98 regulates TMPRSS2 expression in human endothelial cells: key implications for COVID-19. Biomedicines, 8 (11), 462.
   PubMed Web of Science ®Google Scholar
• McDermott, M.M., 2015. Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. Circulation research, 116 (9), 1540–1550.
   PubMed Web of Science ®Google Scholar
• McDermott, M.M., et al., 2004. Leg strength in peripheral arterial disease: associations with disease severity and lower-extremity performance. Journal of vascular surgery, 39 (3), 523–530.
   PubMed Web of Science ®Google Scholar
• McGovern, J., et al., 2021. Relation between body composition, systemic inflammatory response, and clinical outcomes in patients admitted to an urban teaching hospital with COVID-19. The journal of nutrition, 151 (8), 2236–2244.
   PubMed Web of Science ®Google Scholar
• Melton, L.J., 3rd., et al., 2000. Epidemiology of sarcopenia. Journal of the American geriatrics society, 48 (6), 625–630.
   PubMed Web of Science ®Google Scholar
• Mesinovic, J., et al., 2019. Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diabetes, metabolic syndrome and obesity, 12, 1057–1072.
   PubMed Web of Science ®Google Scholar
• Moctezuma-Velázquez, P., et al., 2021. Low thoracic skeletal muscle area is not associated with negative outcomes in patients With COVID-19. American journal of physical medicine & rehabilitation, 100 (5), 413–418.
   PubMed Web of Science ®Google Scholar
• Mori, H., Kuroda, A., et al., 2019. Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes. Journal of diabetes investigation, 10 (5), 1332–1340.
   PubMed Web of Science ®Google Scholar
• Morino, K., et al., 2005. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. The journal of clinical investigation, 115 (12), 3587–3593.
   PubMed Web of Science ®Google Scholar
• Morley, J.E., 2008. Sarcopenia: diagnosis and treatment. The journal of nutrition, health & aging, 12 (7), 452–456.
   PubMed Web of Science ®Google Scholar
• Morley, J. E., Kalantar-Zadeh, K., and Anker, S.D., 2020. COVID-19: a major cause of cachexia and sarcopenia? Journal of cachexia, sarcopenia and muscle, 11 (4), 863–865.
   PubMed Web of Science ®Google Scholar
• Murai, J., et al., 2018. Low muscle quality in Japanese type 2 diabetic patients with visceral fat accumulation. Cardiovascular diabetology, 17 (1), 112.
   PubMedGoogle Scholar
• Murata, Y., et al., 2018. Sarcopenia in elderly patients with type 2 diabetes mellitus: prevalence and related clinical factors. Diabetology international, 9 (2), 136–142.
   PubMedGoogle Scholar
• Nelke, C., et al., 2019. Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine, 49, 381–388.
   PubMed Web of Science ®Google Scholar
• Nikpouraghdam, M., et al., 2020. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: a single center study. Journal of clinical virology, 127, 104378.
   PubMed Web of Science ®Google Scholar
• Nomura, T., et al., 2018. Diabetic polyneuropathy is a risk factor for decline of lower extremity strength in patients with type 2 diabetes. Journal of diabetes investigation, 9 (1), 186–192.
   PubMed Web of Science ®Google Scholar
• Okamura, T., et al., 2019. High brain natriuretic peptide is associated with sarcopenia in patients with type 2 diabetes: a cross-sectional study of KAMOGAWA-DM cohort study. Endocrine journal, 66 (4), 369–377.
   PubMed Web of Science ®Google Scholar
• Okamura, T., et al., 2019. Shortage of energy intake rather than protein intake is associated with sarcopenia in elderly patients with type 2 diabetes: a cross-sectional study of the KAMOGAWA-DM cohort. Journal of diabetes., 11 (6), 477–483.
   PubMed Web of Science ®Google Scholar
• Ong, P.S., et al., 2016. Judicious toggling of mTOR activity to combat insulin resistance and cancer: current evidence and perspectives. Frontiers in pharmacology, 7, 395.
   PubMed Web of Science ®Google Scholar
• Osaka, T., et al., 2018. Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes. Diabetes research and clinical practice, 139, 52–58.
   PubMed Web of Science ®Google Scholar
• Pal, R., and Bhadada, S.K., 2020. COVID-19 and diabetes mellitus: an unholy interaction of two pandemics. Diabetes & metabolic syndrome, 14 (4), 513–517.
   PubMed Web of Science ®Google Scholar
• Palanisami, S., and Kulkarni, V., 2016. The association of muscle mass and body mass index in elderly diabetic patients attending tertiary care center in Bangalore. International journal of medical students, 4 (3), 96–99.
   Google Scholar
• Park, S.W., et al., 2007. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes care, 30 (6), 1507–1512.
   PubMed Web of Science ®Google Scholar
• Pechmann, L.M., et al., 2020. Sarcopenia in Type 2 diabetes mellitus: a cross-sectional observational study. International journal of endocrinology, 2020, 1–9.
   Web of Science ®Google Scholar
• Perry, B.D., et al., 2016. Muscle atrophy in patients with Type 2 diabetes Mellitus: roles of inflammatory pathways, physical activity and exercise. Exercise immunology review, 22, 94–109.
   PubMed Web of Science ®Google Scholar
• Piotrowicz, K., et al., 2021. Post-COVID-19 acute sarcopenia: physiopathology and management. Aging clinical and experimental research, 33 (10), 2887–2898.
   PubMed Web of Science ®Google Scholar
• Price, C.L., et al., 2010. Methylglyoxal modulates immune responses: relevance to diabetes. Journal of cellular and molecular medicine, 14 (6B), 1806–1815.
   PubMed Web of Science ®Google Scholar
• Ramos, A., et al., 2021. Impact of COVID-19 on nutritional status during the first wave of the pandemic. Clinical nutrition, 2021, S0261-5614(21)00238-7.
   Google Scholar
• Reginster, J.Y., et al., 2016. Osteoporosis and sarcopenia: two diseases or one? Current opinion in clinical nutrition and metabolic care, 19 (1), 31–36.
   PubMed Web of Science ®Google Scholar
• Richardson, Set al., 2020. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA, 323 (20), 2052.
   PubMed Web of Science ®Google Scholar
• Riesgo, H., et al., 2021. Prevalence of risk of malnutrition and risk of sarcopenia in a reference hospital for COVID-19: relationship with mortality. Annals of nutrition and metabolism, 77 (6), 324–329.
   PubMed Web of Science ®Google Scholar
• Roncon, L., et al., 2020. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. Journal of clinical virology, 127, 104354.
   PubMed Web of Science ®Google Scholar
• Rosenberg, I.H., 1997. Sarcopenia: origins and clinical relevance. The journal of nutrition, 127 (5 Suppl), 990S–991S.
   PubMedGoogle Scholar
• Rosenberg, I., 1989. Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. The American journal of clinical nutrition, 50 (5), 1231–1233.
   Web of Science ®Google Scholar
• Samuel, V.T., and Shulman, G.I., 2016. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. The journal of clinical investigation, 126 (1), 12–22.
   PubMed Web of Science ®Google Scholar
• Sardu, C., et al., 2020. Hyperglycaemia on admission to hospital and COVID-19. Diabetologia, 63 (11), 2486–2487.
   PubMed Web of Science ®Google Scholar
• Sardu, C., et al., 2020a. Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? Diabetes care, 43 (7), 1408–1415.
   PubMed Web of Science ®Google Scholar
• Sardu, C., et al., 2020b. Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19. Cardiovascular diabetology, 19 (1), 76.
   PubMed Web of Science ®Google Scholar
• Sardu, C., et al., 2022. Effect of hyperglycemia on COVID-19 outcomes: vaccination efficacy, disease severity, and molecular mechanisms. Journal of clinical medicine, 11 (6), 1564.
   PubMed Web of Science ®Google Scholar
• Sartori, R., Romanello, V., and Sandri, M., 2021. Mechanisms of muscle atrophy and hypertrophy: implications in health and disease. Nature communications, 12 (1), 330.
   PubMed Web of Science ®Google Scholar
• Sawaya, Y., et al., 2020. Association between skeletal muscle mass index and lung function/respiratory muscle strength in older adults requiring long-term care or support. Journal of physical therapy science, 32 (11), 754–759.
   PubMedGoogle Scholar
• Sayer, A.A., et al., 2005. Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg? Diabetes care, 28 (10), 2541–2542.
   PubMed Web of Science ®Google Scholar
• Sazlina, S.G., et al., 2020. The prevalence and factors associated with sarcopenia among community living elderly with type 2 diabetes mellitus in primary care clinics in Malaysia. PLoS one, 15 (5), e0233299.
   PubMed Web of Science ®Google Scholar
• Schiaffino, S., et al., 2021. CT-derived chest muscle metrics for outcome prediction in patients with COVID-19. Radiology, 300 (2), E328–E336.
   PubMed Web of Science ®Google Scholar
• Schoen, K., et al., 2019. Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity. BMC infectious diseases, 19 (1), 964.
   PubMed Web of Science ®Google Scholar
• Shi, Q., et al., 2020. Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study. Diabetes care, 43 (7), 1382–1391.
   PubMed Web of Science ®Google Scholar
• Short, K.R., et al., 2005. Decline in skeletal muscle mitochondrial function with aging in humans. Proceedings of the national academy of sciences of the United States of America, 102 (15), 5618–5623.
   PubMed Web of Science ®Google Scholar
• Shou, J., Chen, P.J., and Xiao, W.H., 2020. Mechanism of increased risk of insulin resistance in aging skeletal muscle. Diabetology & metabolic syndrome, 12, 14.
   PubMed Web of Science ®Google Scholar
• Singh, A.K., et al., 2020. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes & metabolic syndrome, 14 (4), 303–310.
   PubMed Web of Science ®Google Scholar
• Sonmez, A., et al., 2021. Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: a nationwide study (TurCoviDia). Journal of diabetes., 13 (7), 585–595.
   PubMed Web of Science ®Google Scholar
• Souza, A.B.F., et al., 2019. Association between sarcopenia and diabetes in community dwelling elderly in the Amazon region – Viver Mais Project. Archives of gerontology and geriatrics, 83, 121–125.
   PubMed Web of Science ®Google Scholar
• Srikanthan, P., and Karlamangla, A.S., 2011. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and nutrition examination survey. The journal of clinical endocrinology and metabolism, 96 (9), 2898–2903.
   PubMed Web of Science ®Google Scholar
• Sugimoto, K., et al., 2019. Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass: the multicenter study for clarifying evidence for sarcopenia in patients with diabetes Mellitus. Journal of diabetes investigation, 10 (6), 1471–1479.
   PubMed Web of Science ®Google Scholar
• Sun, C., et al., 2022. Respiratory strength and pectoralis muscle mass as measures of sarcopenia: relation to outcomes in resected non-small cell lung cancer. The journal of thoracic and cardiovascular surgery, 163 (3), 779–787.e2.
   PubMed Web of Science ®Google Scholar
• Sundar, V., et al., 2021. Sarcopenia with co-existent type 2 diabetes mellitus is associated with worse clinical outcomes among hospitalised cardiac patients. Clinical nutrition Espen, 46, 380–385.
   PubMed Web of Science ®Google Scholar
• Sung, M.J., et al., 2020. Sarcopenia is independently associated with the degree of liver fibrosis in patients with Type 2 Diabetes Mellitus. Gut and liver, 14 (5), 626–635.
   PubMed Web of Science ®Google Scholar
• Tamura, Y., et al., 2018. Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinic. BMC geriatrics, 18 (1), 264.
   PubMedGoogle Scholar
• Tehrani, S., et al., 2021. Risk factors for death in adult COVID-19 patients: frailty predicts fatal outcome in older patients. International journal of infectious diseases, 102, 415–421.
   PubMed Web of Science ®Google Scholar
• Thiebaud, D., et al., 1982. The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man. Diabetes, 31 (11), 957–963.
   PubMed Web of Science ®Google Scholar
• Trierweiler, H., et al., 2018. Sarcopenia: a chronic complication of type 2 diabetes mellitus. Diabetology & metabolic syndrome, 10 (1), 25.,
   PubMedGoogle Scholar
• van Vught, L.A., et al., 2016. Admission hyperglycemia in critically ill sepsis patients: association with outcome and host response. Critical care medicine, 44 (7), 1338–1346.
   PubMed Web of Science ®Google Scholar
• Velázquez-Alva, M.C., et al., 2020. Sarcopenia, nutritional status and type 2 diabetes mellitus: a cross-sectional study in a group of Mexican women residing in a nursing home. Nutrition & dietetics. 77 (5), 515–522.
   PubMed Web of Science ®Google Scholar
• Wan, S., et al., 2020. Clinical features and treatment of COVID-19 patients in northeast Chongqing. Journal of medical virology, 92 (7), 797–806.
   PubMed Web of Science ®Google Scholar
• Wang, D., et al., 2020. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected pneumonia in Wuhan, China. JAMA, 323 (11), 1061–1069.
   PubMed Web of Science ®Google Scholar
• Wang, T., et al., 2016. Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly. Scientific reports, 6, 38937.
   PubMed Web of Science ®Google Scholar
• Wang, X.H., and Mitch, W.E., 2014. Mechanisms of muscle wasting in chronic kidney disease. Nature reviews. nephrology, 10 (9), 504–516.
   PubMed Web of Science ®Google Scholar
• Welch, A.A., Hayhoe R.P.G., and Cameron, D., 2020. The relationships between sarcopenic skeletal muscle loss during ageing and macronutrient metabolism, obesity and onset of diabetes. The proceedings of the nutrition society, 79 (1), 158–169.
   PubMed Web of Science ®Google Scholar
• Wierdsma, N.J., et al., 2021. Poor nutritional status, risk of sarcopenia and nutrition related complaints are prevalent in COVID-19 patients during and after hospital admission. Clinical nutrition ESPEN, 43, 369–376.
   PubMed Web of Science ®Google Scholar
• Wilkinson, T.J., et al., 2022. Sarcopenic obesity and the risk of hospitalization or death from coronavirus disease 2019: findings from UK Biobank. JCSM rapid communications, 5 (1), 3–9.
   PubMedGoogle Scholar
• Wiriya, B., et al., 2019. Prevalence and predictors of sarcopenia in older people with Type 2 diabetes. Pacific rim international journal of nursing research, 23 (3), 297–309.
   Web of Science ®Google Scholar
• Wu, J., et al., 2020. Skeletal muscle antagonizes antiviral CD8þ T cell exhaustion. Science advances., 6 (24), eaba3458.
   PubMed Web of Science ®Google Scholar
• Yan, Y., et al., 2020. Clinical characteristics and outcomes of patients with severe Covid-19 with diabetes. BMJ open diabetes research & care, 8 (1), e001343.
   PubMed Web of Science ®Google Scholar
• Yi, X., et al., 2021. Myosteatosis predicting risk of transition to severe COVID-19 infection. Clinical nutrition, 2021, S0261-5614(21)00281-8.
   Google Scholar
• Yin, Y., et al., 2021. The epidemiology, pathophysiological mechanisms, and management toward COVID-19 patients with Type 2 diabetes: a systematic review. Primary care diabetes, 15 (6), 899–909.
   PubMed Web of Science ®Google Scholar
• Yoon, J.W., et al., 2016. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean longitudinal study on health and aging. Diabetes & metabolism journal, 40 (2), 140–146.
   PubMed Web of Science ®Google Scholar
• Young, B.E., et al., 2020. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA, 323 (15), 1488–1494.
   PubMed Web of Science ®Google Scholar
• Zamboni, M., et al., 2008. Sarcopenic obesity: a new category of obesity in the elderly. Nutrition, metabolism, and cardiovascular diseases, 18 (5), 388–395.
   PubMed Web of Science ®Google Scholar
• Zhang, J.J., et al., 2020. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy, 75 (7), 1730–1741.
   PubMed Web of Science ®Google Scholar
• Zhou, L., Liu, C., and Yang, C., 2021. Comment on “COVID-19: a major cause of cachexia and sarcopenia” by Morley et al. Journal of cachexia, sarcopenia and muscle, 12 (1), 233–234.
   PubMed Web of Science ®Google Scholar
• Zhu, L., et al., 2020. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing Type 2 diabetes. Cell metabolism, 31 (6), 1068–1077.e3.
   PubMed Web of Science ®Google Scholar